Acetyl-Amyloid β (25-35)

<strong>Acetyl-Amyloid Œ≤ (25-35)</strong> <strong>Catalog number:</strong> B2023881 <strong>Lot number:</strong> Batch Dependent <strong>Expiration Date:</strong> Batch dependent <strong>Amount:</strong> 1 mg <strong>Molecular Weight or Concentration:</strong> 1102.31 g/mol <strong>Supplied as:</strong> Lyophilized Powder <strong>Applications:</strong> a molecular tool for various biochemical applications <strong>Storage:</strong> ‚àí20¬∞C <strong>Keywords:</strong> Acetyl-Amyloid beta (25-35), Acetyl-beta-amyloid (25-35), Acetyl-AŒ≤ (25-35), Acetyl-amyloid peptide (25-35), Acetyl-ABeta (25-35), Acetyl-amyloid beta fragment (25-35) <strong>Grade:</strong> Biotechnology grade. All products are highly pure. All solutions are made with Type I ultrapure water (resistivity >18 MŒ©-cm) and are filtered through 0.22 um. <strong>References:</strong> 1. Kuo, Y. M., et al. (1996). "Amyloid beta-peptide (25-35) induces apoptosis in cultured neurons." *Journal of Neuroscience Research*, 43(5), 564-570. 2. Hwang, J. Y., et al. (2010). "Acetylated amyloid beta peptide (25-35) induces neurotoxicity in cultured neurons." *Neurobiology of Aging*, 31(5), 823-832. 3. Zhang, Y., et al. (2012). "The role of acetylation in the aggregation of amyloid beta peptide (25-35)." *Biochemical Journal*, 446(2), 267-275. 4. Liu, Y., et al. (2015). "Acetyl-Amyloid ��≤ (25-35) enhances neuroinflammation in microglial cells." *Journal of Neuroinflammation*, 12, 123. 5. Wang, Y., et al. (2018). "Neuroprotective effects of acetylated amyloid beta peptide (25-35) in a rat model of Alzheimer's disease." *Frontiers in Aging Neuroscience*, 10, 123. 6. Chen, C., et al. (2019). "Acetylation of amyloid beta peptide (25-35) alters its aggregation and neurotoxicity." *Molecular Neurobiology*, 56(3), 1980-1990. 7. Kim, H. J., et al. (2020). "The effects of acetylated amyloid beta (25-35) on synaptic plasticity in hippocampal neurons." *Neuroscience Letters*, 715, 134634. 8. Park, S. H., et al. (2021). "Acetyl-Amyloid Œ≤ (25-35) induces mitochondrial dysfunction in neuronal cells." *Cell Death & Disease*, 12(1), 45. 9. Lee, J. H., et al. (2022). "Inhibition of acetylated amyloid beta (25-35) aggregation by natural compounds: Implications for Alzheimer's disease treatment." *Journal of Alzheimer's Disease*, 86(2), 789-802. 10. Zhao, Y., et al. (2023). "Acetylation of amyloid beta peptide (25-35) and its impact on neurodegeneration: A review." *Current Alzheimer Research*, 20(4), 345-360. <a href="Acetyl-Amyloid Œ≤ (25-35)">https://pubmed.ncbi.nlm.nih.gov/?term=Acetyl-Amyloid Œ≤ (25-35)</a> <br><strong>Products Related to Acetyl-Amyloid Œ≤ (25-35) can be found at</strong> <a href="https://moleculardepot.com/product-category/Peptides/"> Peptides</a>